RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 26 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $257,000 | -13.8% | 950,900 | +22.1% | 0.00% | -100.0% |
Q4 2015 | $298,000 | +38.6% | 778,800 | +34.3% | 0.00% | 0.0% |
Q3 2015 | $215,000 | -13.3% | 580,000 | +14.4% | 0.00% | 0.0% |
Q2 2015 | $248,000 | +1553.3% | 507,000 | +2291.5% | 0.00% | – |
Q1 2015 | $15,000 | – | 21,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 2,252,964 | $6,804,000 | 0.34% |
SPHERA FUNDS MANAGEMENT LTD. | 175,815 | $531,000 | 0.13% |
THOMPSON DAVIS & CO., INC. | 0 | $9,000 | 0.01% |
Spark Investment Management LLC | 11,200 | $33,000 | 0.01% |
Virtu KCG Holdings LLC | 55,599 | $167,000 | 0.00% |
Ground Swell Capital, LLC | 302 | $1,000 | 0.00% |
JANE STREET GROUP, LLC | 62,219 | $188,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,668 | $5,000 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 61 | $0 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 11 | $33,000 | 0.00% |